B.C. limits sale of 2 more diabetes drugs used for weight loss
The rule bans pharmacies from selling tirzepatide (sold as Mounjaro) and dulaglutide (sold as Trulicity) to non-Canadians or non-permanent residents who don't go in person to pick up the medications.
The two drugs are being added to an existing regulation first announced in 2023, which limits sales of semaglutide, a medication sold under the brand names Ozempic, Wegovy, and Rybelsus.
The medications are still available to non-Canadians with a valid prescription from a Canadian doctor or nurse practitioner as long as they go to pick up the medication in person, according to a statement from the ministry.
They are also still available from B.C. pharmacies, online or in person, to B.C. residents, Canadian citizens and permanent residents who have a valid prescription.
In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide injections that help regulate blood sugar levels and appetite. Dr. Tom Elliott, medical director at B.C. Diabetes, says that semaglutide injections have revolutionized his practice, and they are astonishingly effective.
Health Minister Josie Osborne says the drugs' use for weight loss is driving shortages in several countries, including the United States.
"Tirzepatide, dulaglutide and semaglutide are prescription drugs approved for the management of Type 2 diabetes, but their off-label use for weight loss is driving shortages of the drugs in several countries, including the United States," she said in a press release.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
17 minutes ago
- CTV News
Cyclist rushed to trauma centre after collision in Toronto's west end
An ambulance arrives at a Toronto hospital on September 25, 2018 in this file photo. A cyclist has been rushed to a trauma centre via emergency run following a collision in Toronto's west end. Police said the cyclist was struck at around 5:45 a.m. in the area of Bloor and Dufferin streets. The male rider is currently in hospital receiving treatment.
CBC
an hour ago
- CBC
How researchers are mapping genetics in N.B. to detect inherited diseases sooner
Researchers at Vitalité Health Network imagine a health-care system where patients are screened early for a disorder or disease they inherited from their parents, and mothers know exactly what health problems they could pass down to their children before ever getting pregnant. But first, medical teams need to know which genetic variants are common in specific regions of New Brunswick. Luckily, we are built of microscopic indicators that researchers in Moncton are studying so they can figure that out. "We have thousands of genes," Jean Mamelona, who runs the provincial program of medical genetics, said. "We are going, specifically, to analyze the genes to see if there is a defect or … a default on the gene." Mamelona and his research team at the Dr. Georges-L.-Dumont Hospital are touring the province to map people's genes to build the first database of its kind for each of the seven health zones in the province. Genes provide a wealth of information about the body. But this research is focused on finding defects, otherwise known as variances or mutations. These can cause genetic disorders. The hope is that medical teams will use that information to screen people earlier for conditions such as sickle cell anemia, cystic fibrosis and Huntington's, among others. It could also be invaluable to inform more precise neonatal screening, Mamelona said. "We can plan precision medicine for the area," he said. The project, which began in 2018 and is partly funded by Research N.B., is expected to be complete once 60 people in each of the seven health zones have been tested by the end of 2027. What results among Acadians are telling us so far Teams have been testing 60 participants in each health zone who can provide medical information and a swab of DNA to be tested. So far, the team has tested people near Moncton, on the Acadian Peninsula, and in Restigouche and Madawaska. WATCH | 'It's what we call a bottleneck effect' A map of New Brunswickers' genes is being drawn, and here's what it could mean 2 hours ago Researchers in Moncton are studying 60 people in each of the seven health zones in New Brunswick to find common variants in their genes. The hope is that medical teams will be able to use the information to screen patients sooner for inherited diseases and disorders. Results from some areas, such as the Acadian Peninsula and northwest regions, have not yet been released to the public. The results from Zone 1, in the southeast, show that Acadians who were tested have similar genetic variants that are likely being passed down from generation to generation. "We have seen that there are some variants that are really more frequent, compared to Caucasian populations elsewhere around the globe," Mamelona said. Forty-three of the 60 participants in the southeast, or 71 per cent of them, were found to be carrying at least one variant. One of the variants was detected in 11 individuals. For privacy reasons, the researchers do not disclose the specific diseases that each of the variants they found could be linked to. To historian and Acadian genealogist Denis Savard, the results are no surprise. He said the similarities in Acadian genes are likely caused by a common thing that happens among smaller ancestral groups. "It's what we call a bottleneck effect," Savard said. "[It's] where only a few families, relatively speaking, start off the population, so there's a limited number of genes to start off even though there's always people coming in and adding to the population." Acadians actually experienced the bottleneck effect twice, Savard said. It happened once when a limited number of mostly French settlers came to New Brunswick and Nova Scotia in the 1600s. The same thing happened again after Acadians were expelled from the region in 1755, and an even smaller number of them returned to rebuild communities. "If you look at Restigouche, it's pretty much the same families for over 150 years, same for Memramcook area," Savard said. To the research team, Acadians are a strong example of why the medical community could benefit from more in-depth genetic testing, given that early results point to largely homogeneous genetic variances. In other words, Mamelona said, if there is a higher prevalence of carriers for the same genetic variants, and we can confirm them across the province, we can screen new generations for them. Researchers are now trying to recruit in the Miramichi area as they turn their focus to areas of English descent. Saint John and Fredericton are next on the list. Participants must be at least 19 years old, be covered by medicare, not be expecting a child and have two grandparents who were born in that specific area to qualify for the study.
CTV News
an hour ago
- CTV News
Tribunal sides with disabled woman denied ultrasound at Calgary clinic
Stephanie Chipeur, a law professor at the University of Calgary who filed a human rights complaint against a diagnostics clnic, is seen in an undated handout photo. THE CANADIAN PRESS/Handout - Stephanie Chipeur (Mandatory Credit) An Alberta woman who filed a human rights complaint after being turned away at a clinic for an ultrasound says she hopes her recent win paves the way for better accommodations for disabled patients. Stephanie Chipeur complained to the Alberta Human Rights Tribunal after the Calgary diagnostics clinic refused to schedule her for an appointment in 2021 unless she had a caretaker also attend to lift her from her wheelchair onto an exam table. Chipeur says she is quadriplegic and has been in a wheelchair since she injured her spinal cord in a car crash. 'They said we won't be able to give you an appointment, because we don't do anything to do with transfers. So I was kind of like, this is not OK,' said Chipeur, a law professor at the University of Calgary. 'I talked to my doctor about this refusal, and she was like, 'Yeah, this happens to my patients all the time.'' The tribunal ruled this week that the clinic, run by EFW Radiology, discriminated against Chipeur. She was awarded $15,000 in damages, commissioner Erika Ringseis said in the written decision. The decision says Chipeur's physiatrist told her to get a deep vein ultrasound to assess a possible blood clot. When Chipeur called to set up an appointment, she was told by the clinic that staff couldn't lift patients onto the exam table, and she would need to bring a caregiver. Asked about using a mechanical lift, the clinic told Chipeur only a hospital had such equipment. 'I thought it was reasonable that they should — I would expect at least one of their 12 locations in Calgary would have a lift,' Chipeur said. Chipeur said she got an ultrasound in a hospital, but then had to get a second of a different type a month later — one that she could only get at the clinic because the hospital didn't have the staff, the decision says. 'The complainant faced an untenable situation where she believed that she was being denied all opportunity to get the necessary MSK ultrasound,' Ringseis says in the decision. A friend later referred Chipeur to a small clinic that did the ultrasound as she sat in her wheelchair. 'It was clear to the tribunal member that it was so obvious that they could have been more accommodating, and they just were being difficult,' Chipeur said. At the tribunal hearing, the clinic argued staff were not permitted to lift patients due to safety risks and that Chipeur didn't experience an 'adverse impact' with the denial. Ringseis disagreed. 'The complainant was denied a service by the respondent, which resulted in a delay before she could receive a necessary ultrasound,' she says. 'The inconvenience and loss of time associated with needing to schedule an alternative location is an adverse impact, even if the complainant was able eventually to receive the ultrasound.' Dr. David Lautner from EFW Radiology said in a statement that the clinic has updated its policies and procedures, including the addition of steps to support patients who need help being transferred to exam tables. 'We recognize that the experience of this specific patient in 2021 did not reflect the high standards of accessibility and patient care we are committed to providing,' Lautner said. 'We continue to proactively evaluate and invest in additional equipment to further enhance accessibility. Our goal is to ensure equitable, barrier-free access to diagnostic care for all patients.' Chipeur said she's happy the tribunal sided with her and hopes diagnostic clinics take steps to accommodate people with disabilities. 'This decision, I needed it, so that all of the clinics wouldn't be able to say no to people like me anymore,' she said. This report by The Canadian Press was first published July 18, 2025. Aaron Sousa, The Canadian Press
